Law360, New York (August 15, 2012, 8:47 PM ET) -- Santarus Inc. and the University of Missouri launched a patent infringement suit against Dr. Reddy's Laboratories Ltd. on Wednesday in New Jersey, continuing an ongoing fight to block generic versions of the heartburn drug Zegerid.
Santarus said it was suing Dr. Reddy's in a filing with the U.S. Securities and Exchange Commission, in response to the Indian-based pharmaceutical company's filing of an abbreviated new drug application with the U.S. Food and Drug Administration regarding its intent to market a generic version of the omeprazole and sodium...
Santarus Seeks To Block Dr. Reddy's Generic Zegerid
To view the full article, take a free trial now.
